2024 |
Glenmark Pharmaceuticals Ltd.
|
Executive Director (Corporate) |
6.1 Cr |
32.7 % |
2023 |
Glenmark Pharmaceuticals Ltd.
|
Executive Director (Corporate) |
4.6 Cr |
-1.6 % |
2022 |
Glenmark Pharmaceuticals Ltd.
|
Director (Corporate Affairs) |
4.7 Cr |
14.5 % |
2021 |
Glenmark Pharmaceuticals Ltd.
|
Director (Corporate Affairs) |
4.1 Cr |
-10.0 % |
2020 |
Glenmark Pharmaceuticals Ltd.
|
Director (Corporate Affairs) |
4.5 Cr |
5.3 % |
2019 |
Glenmark Pharmaceuticals Ltd.
|
Director (Corporate Affairs) |
4.3 Cr |
-0.0 % |
2018 |
Glenmark Pharmaceuticals Ltd.
|
Director (Corporate Affairs) |
4.3 Cr |
10.8 % |
2017 |
Glenmark Pharmaceuticals Ltd.
|
Director (Corporate Affairs) |
3.9 Cr |
16.2 % |
2016 |
Glenmark Pharmaceuticals Ltd.
|
Director (Corporate Affairs) |
3.3 Cr |
- |